Nektar Therapeutics
NKTR
#5904
Rank
โ‚น93.78 B
Marketcap
โ‚น4,610
Share price
-4.83%
Change (1 day)
262.44%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): -โ‚น688.07

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น724.39. In 2024 the company made an earnings per share (EPS) of -โ‚น805.29 an increase over its 2023 EPS that were of -โ‚น1,990.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น688.07-14.56%
2024-โ‚น805.29-59.54%
2023-โ‚น1,990-25.89%
2022-โ‚น2,686-31.12%
2021-โ‚น3,89914.86%
2020-โ‚น3,395-1.19%
2019-โ‚น3,436-163.96%
2018โ‚น5,372-725.4%
2017-โ‚น858.91-42.73%
2016-โ‚น1,50083.33%
2015-โ‚น818.0139.53%
2014-โ‚น586.24-69.29%
2013-โ‚น1,909-6.67%
2012-โ‚น2,045

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
โ‚น1,184-263.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น156.33-121.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น690.20-195.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
โ‚น0.91-100.13%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น275.85-138.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
-โ‚น59.99-91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
โ‚น188.14-125.97%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
โ‚น948.84-230.98%๐Ÿ‡บ๐Ÿ‡ธ USA